Abstract
Cell-free fetal DNA constitutes approximately 10 % of the cell-free DNA found in maternal plasma and can be used as a reliable source of fetal genetic material for noninvasive prenatal diagnosis (NIPD) from early pregnancy. The relatively high levels of maternal background can make detection of paternally inherited point mutations challenging. Diagnosis of inheritance of autosomal recessive disorders using qPCR is even more challenging due to the high background of mutant maternal allele. Digital PCR is a very sensitive modified method of quantitative real-time PCR (qPCR), allowing absolute quantitation and rare allele detection without the need for standards or normalization. Samples are diluted and then partitioned into a large number of small qPCR reactions, some of which contain the target molecule and some which do not; the proportion of positive reactions can be used to calculate the concentration of targets in the initial sample. Here we discuss the use of digital PCR as an accurate approach to NIPD for single-gene disorders.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Vogelstein B, Kinzler KW (1999) Digital PCR. Proc Natl Acad Sci U S A 96:9236–9241
Azuara D, Ginesta MM, Gausachs M et al (2012) Nanofluidic digital PCR for KRAS mutation detection and quantification in gastrointestinal cancer. Clin Chem 58:1332–1341
Wang J, Ramakrishnan R, Tang Z et al (2010) Quantifying EGFR alterations in the lung cancer genome with nanofluidic digital PCR arrays. Clin Chem 56:623–632
Yung TK, Chan HC, Mok TS et al (2009) Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients. Clin Cancer Res 15:2076–2084
Lun FM, Tsui NB, Chan KC et al (2008) Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci U S A 105:19920–19925
Barrett AN, McDonnell TC, Chan KC et al (2012) Digital PCR analysis of maternal plasma for noninvasive detection of sickle cell anemia. Clin Chem 58:1026–1032
Tsui NB, Kadir RA, Chan KC et al (2011) Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood 117:3684–3691
Henrich TJ, Gallien S, Li JZ et al (2012) Low-level detection and quantitation of cellular HIV-1 DNA and 2-LTR circles using droplet digital PCR. J Virol Methods 186:68–72
Strain MC, Lada SM, Luong T et al (2013) Highly precise measurement of HIV DNA by droplet digital PCR. PLoS One 8:e55943. doi:10.1371/journal.pone.0055943
Hua Z, Rouse JL, Eckhardt AE et al (2010) Multiplexed real-time polymerase chain reaction on a digital microfluidic platform. Anal Chem 82:2310–2316
Hindson BJ, Ness KD, Masquelier DA et al (2011) High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem 83:8604–8610
Weaver S, Dube S, Mir A et al (2010) Taking qPCR to a higher level: analysis of CNV reveals the power of high throughput qPCR to enhance quantitative resolution. Methods 50:271–276
Whale AS, Huggett JF, Cowen S et al (2012) Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation. Nucleic Acids Res 40:e82. doi:10.1093/nar/gks203
Belgrader P, Tanner SC, Regan JF et al (2013) Droplet digital PCR measurement of HER2 copy number alteration in formalin-fixed paraffin-embedded breast carcinoma tissue. Clin Chem 59:991–994
Gevensleben H, Garcia-Murillas I, Graeser MK et al (2013) Noninvasive detection of HER2 amplification with plasma DNA digital PCR. Clin Cancer Res 19:3276–3284
Heredia NJ, Belgrader P, Wang S et al (2013) Droplet digital PCR quantitation of HER2 expression in FFPE breast cancer samples. Methods 59:S20–S23. doi:10.1016/j.ymeth.2012.09.012
Dube S, Qin J, Ramakrishnan R (2008) Mathematical analysis of copy number variation in a DNA sample using digital PCR on a nanofluidic device. PLoS One 3:e2876. doi:10.1371/journal.pone.0002876
Zimmermann BG, Dudarewicz L (2008) Real-time quantitative PCR for the detection of fetal aneuploidies. Methods Mol Biol 444:95–109
Tabor A, Alfirevic Z (2010) Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 27:1–7
Alfirevic Z, Sundberg K, Brigham S (2003) Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev 3, CD003252
Lo YM, Corbetta N, Chamberlain PF et al (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350:485–487
Alberry MS, Maddocks DG, Hadi MA et al (2009) Quantification of cell free fetal DNA in maternal plasma in normal pregnancies and in pregnancies with placental dysfunction. Am J Obstet Gynecol 200(98):e1–e6. doi:10.1016/j.ajog.2008.07.063
Birch L, English CA, O’Donogue K et al (2005) Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem 51:312–320
Lun FM, Chiu RW, Allen Chan KC et al (2008) Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 54:1664–1672
Lo YM, Chan KC, Sun H et al (2010) Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2:61ra91. doi:10.1126/scitranslmed.3001720
Lo YM, Zhang J, Leung TN et al (1999) Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 64:218–224
Hill M, Finning K, Martin P et al (2011) Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet 80:68–75
Daniels G, Finning K, Martin P et al (2009) Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat Diagn 29:101–107
Chiu RW, Chan KC, Gao Y et al (2008) Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 105:20458–20463
Fan HC, Blumenfeld YJ, Chitkara U et al (2008) Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 105:16266–16271
Boon EM, Faas BH (2013) Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies. Prenat Diagn 33:563–568
Chitty LS, Hill M, White H et al (2012) Non-invasive prenatal testing for aneuploidy-ready for prime time? Am J Obstet Gynecol 206:269–275
Lench N, Barrett A, Fielding S et al (2013) The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress made. Prenat Diagn 33:555–562
Rozen S, Skaletsky HJ (1998) Primer3. Code available at http://www-genome.wi.mit.edu/genome_software/other/primer3.html
Sikora A, Zimmermann BG, Rusterholz C et al (2010) Detection of increased amounts of cell-free fetal DNA with short PCR amplicons. Clin Chem 56:136–138
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Barrett, A.N., Chitty, L.S. (2014). Developing Noninvasive Diagnosis for Single-Gene Disorders: The Role of Digital PCR. In: Biassoni, R., Raso, A. (eds) Quantitative Real-Time PCR. Methods in Molecular Biology, vol 1160. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0733-5_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0733-5_17
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0732-8
Online ISBN: 978-1-4939-0733-5
eBook Packages: Springer Protocols